The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotes

European Cytokine Network

Volumn 14, Issue 4, 2003, Pages 234-237

  Heesen, Michael ^a   Bloemeke, Brunhilde ^b   Kunz, Dagmar ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Endotoxin; Genetic polymorphism; Interleukin 6; Polymerase chain reaction; Toll like receptor 4; Tumor necrosis factor

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CELL COUNT; CELL DENSITY; CHEMOLUMINESCENCE; CYTOKINE PRODUCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; GRAM NEGATIVE BACTERIUM; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFECTION SENSITIVITY; MONOCYTE; POLYMERASE CHAIN REACTION; SEPTIC SHOCK; WILD TYPE;

AMINO ACID SUBSTITUTION; ANTIGENS, CD14; CYTOKINES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MEMBRANE GLYCOPROTEINS; MONOCYTES; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 1642457396     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274: 10689.
2. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 282: 2085.
3. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25: 187.
4. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. New England J. Med. 347: 185.
5. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. 2002. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186: 1522.
6. Lorenz E, Mira JP, Frees KL, Schwanz DA. 2002. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162: 1028.
7. Heesen M, Wessipe M, Kunz D, Vasickova K, Blomeke B. 2003. Rapid and reliable genotyping for the Toll-like receptor 4 A896G polymorphism using fluorescence-labeled hybridization probes in a real-time polymerase chain reaction assay. Clin. Chim. Acta 333: 47.
8. Heesen M, Blomeke B, Schluter B, Heussen N, Rossaint R, Kunz D. 2001. Lack of association between the -260 C→T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intensive Care Med. 27: 1770.
9. Heesen M, Bloemeke B, Heussen N, Kunz D. 2002. Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines. Crit. Care Med. 30: 664.
10. Schmitt C, Humeny A, Becker C-M, Brune K, Pahl A. 2002. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharid-of TLR4 mutant alleles. Clin. Chem. 48: 1661.
11. Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B. 2003. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit. Care Med. 31: 211.
12. Heesen M, Bloemeke B, Bachmann-Mennenga B, Kunz D. 2002. The CD 14-260 C→T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G→A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytes. Eur. Cytokine Netw. 13: 230.
13. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J. 1998. Tumor necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 113: 401.
14. Flach R, Majetschak M, Heukamp T, Jennissen V, Flohe S, Boergermann J, Obertacke U, Schade FU. 1999. Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11: 173.
15. Majetschak M, Flach R, Heukamp T, Jennissen V, Obertacke U, Neudeck F, Schmit-Neuerburg KP, Schade FU. 1997. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J. Trauma 43: 880.
16. Majetschak M, Flach R, Kreuzfelder E, Jennissen V, Heukamp T, Neudeck F, Schmit-Neuerburg KP, Obertacke U, Schade FU. 1999. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit. Care Med. 27: 313.
17. Le JM, Vilcek J. 1988. Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61: 588.
18. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102: 1369.
19. Terry CF, Loukaci V, Green FR. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275: 18138.
20. Rein TR, Forster A, Krause A, Winnacker EL, Zorbas H. 1995. Organization of the α-globin promoter and possible role of nuclear factor I in an α-globin inducible and a noninducible cell line. J. Biol. Chem. 270: 19643.
21. Liu Y, Bernard HU, Apt D. 1997. NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing. J. Biol. Chem. 272: 10739.
22. Gibrat JF, Garnier J, Robson B. 1987. Further developments of protein secondary structure prediction using information theory. New parameters and consideration of residue pairs. J. Mol. Biol. 198: 425.
23. Kroeger KM, Carville KS, Abraham LJ. 1997. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol. Immunol. 34: 391.
24. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. 1997. Effects of a polymorphism in the human tumor necrosis factor-a promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195.
25. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A. 1999. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum. Mol. Genet. 8: 1443.
26. Child NJA, Yang IA, Pulletz MC, de Courcy-Golder K, Andrews AL, Pappachan VJ, Holloway JW. 2003. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 31: 652.
27. Feterowski C, Emmanuilidis K, Miethke T, Gerauer K, Rump M, Ulm K, Holzmann B, Weighardt H. 2003. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109: 426.
28. Erridge C, Stewart J, Poxton IR. 2003. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197: 1787.
29. Schwartz DA. 2001. The role of TLR4 in endotoxin responsiveness in humans. J. Endotoxin. Res. 7: 389.
30. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Qureshi N, Michalek SM, Vogel SN. 2001. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69: 1477.
31. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165: 618.